Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of ARS 256.83 trillion. The enterprise value is 289.11 trillion.

Market Cap	256.83T
Enterprise Value	289.11T

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 13.73 and the forward PE ratio is 9.05.

PE Ratio	13.73
Forward PE	9.05
PS Ratio	3.74
PB Ratio	4.95
P/TBV Ratio	21.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.89, with an EV/FCF ratio of 15.81.

EV / Earnings	15.45
EV / Sales	3.60
EV / EBITDA	7.89
EV / EBIT	9.42
EV / FCF	15.81

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	926.96M
Profits Per Employee	252.82M
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

In the past 12 months, Merck & Co. has paid 2.92 trillion in taxes.

Income Tax	2.92T
Effective Tax Rate	13.48%

Stock Price Statistics

The stock price has decreased by -37.04% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-37.04%
50-Day Moving Average	18,894.00
200-Day Moving Average	22,361.50
Relative Strength Index (RSI)	64.58
Average Volume (20 Days)	4,986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.17

Income Statement

In the last 12 months, Merck & Co. had revenue of ARS 68.59 trillion and earned 18.71 trillion in profits. Earnings per share was 7,381.51.

Revenue	68.59T
Gross Profit	52.87T
Operating Income	26.20T
Pretax Income	21.64T
Net Income	18.71T
EBITDA	30.90T
EBIT	26.20T
Earnings Per Share (EPS)	7,381.51

Full Income Statement

Balance Sheet

The company has 9.90 trillion in cash and 37.39 trillion in debt, giving a net cash position of -27,488.53 billion.

Cash & Cash Equivalents	9.90T
Total Debt	37.39T
Net Cash	-27,488.53B
Net Cash Per Share	n/a
Equity (Book Value)	51.94T
Book Value Per Share	20,614.71
Working Capital	11.08T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.40 trillion and capital expenditures -4,119.63 billion, giving a free cash flow of 18.28 trillion.

Operating Cash Flow	22.40T
Capital Expenditures	-4,119.63B
Free Cash Flow	18.28T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

This stock pays an annual dividend of 503.41, which amounts to a dividend yield of 2.50%.

Dividend Per Share	503.41
Dividend Yield	2.50%
Dividend Growth (YoY)	76.90%
Years of Dividend Growth	2
Payout Ratio	45.54%
Buyback Yield	0.30%
Shareholder Yield	2.79%
Earnings Yield	7.28%
FCF Yield	7.12%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score	4.7
Piotroski F-Score	7